154 results
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
Type 2 Medication Management ... and Titration Algorithm ... - Established ASCVD ... Without established ASCVD ... #Algorithm #endocrinology
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
events in T2DM + ASCVD ... or ASCVD risk; ... or ASCVD risk. ... SGLT2 #inhibitors #EBM ... visualabstract #table
Management of Acute Diarrhea #Management #EM #IM #Diarrhea #Algorithm #Ddxof
Management of Acute ... Diarrhea #Management ... #EM #IM #Diarrhea ... #Algorithm #Ddxof
An Algorithm for the Evaluation of Chest Pain #Diagnosis #Management #EM #IM #Chest #Pain #ChestPain #Evaluation
An Algorithm for ... Pain #Diagnosis #Management ... #EM #IM #Chest ... #Differential #Algorithm
Centor - Clinical Decision Rule for Management of Sore Throat #Diagnosis #Management #EM #IM #Centor #Criteria
Decision Rule for Management ... Throat #Diagnosis #Management ... #EM #IM #Centor ... #StrepThroat #Algorithm
Algorithm for the Evaluation and Management of NSVT #Diagnosis #Management #EM #IM #Cardiology #NSVT #Evaluation #NonSustained
Algorithm for the ... Evaluation and Management ... NSVT #Diagnosis #Management ... #EM #IM #Cardiology ... VentricularTachycardia #Algorithm
Simplified Algorithm for bradycardia with a pulse (Adapted from ACLS 2010) #Management #EM #IM #Prehosp #ACLS
Simplified Algorithm ... from ACLS 2010) #Management ... #EM #IM #Prehosp ... #Bradycardia #Algorithm
Simplified Algorithm for tachycardia with a pulse (Adapted from ACLS 2010) #Management #EM #IM #Prehosp #ACLS
Simplified Algorithm ... from ACLS 2010) #Management ... #EM #IM #Prehosp ... #Tachycardia #Algorithm
Catecholamine Vasopressor Effect Sites and Indications #Pathophys #Management #EM #IM #PCC #Catecholamine #Comparison #Table #Epi #Norepi
Indications #Pathophys #Management ... #EM #IM #PCC #Catecholamine ... #Comparison #Table
The Evidence for Aspirin - Visual Abstract

Three new aspirin trials in three different populations: 
 -
Moderate Risk (ASCVD ... ASCEND #ASPREE #Management ... #EBM #Trials